Sino Medical Sciences Technology Inc. (SHA:688108)
China
· Delayed Price · Currency is CNY 10.61
+0.74 (7.50%)
May 27, 2025, 2:45 PM CST
SHA:688108 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | - | -3.89 | -39.63 | -162.38 | -130.77 | 22.49 | Upgrade
|
| Depreciation & Amortization | - | 78.16 | 60.79 | 63.17 | 65.41 | 38.3 | Upgrade
|
| Other Amortization | - | 24.39 | 26.57 | 24.11 | 15.48 | 7.91 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.29 | 1.41 | -0 | -0.19 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 18.14 | 0.14 | 2.22 | 0.08 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -11.19 | 4.67 | 4.11 | 0.29 | -6.26 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -1.41 | 1.33 | -0.54 | 0.48 | Upgrade
|
| Other Operating Activities | - | 5.37 | 5.37 | 6.78 | 11.62 | 2.02 | Upgrade
|
| Change in Accounts Receivable | - | 10.31 | 18.86 | 7.73 | 100.12 | -13.75 | Upgrade
|
| Change in Inventory | - | 18.7 | -14.53 | -18.38 | -27.79 | 3.65 | Upgrade
|
| Change in Accounts Payable | - | 0.34 | 3.03 | 8.04 | -59.48 | 15.26 | Upgrade
|
| Change in Other Net Operating Assets | - | 3.27 | 7.62 | - | - | - | Upgrade
|
| Operating Cash Flow | - | 131.24 | 56.84 | -111.31 | -60.13 | 70.51 | Upgrade
|
| Operating Cash Flow Growth | - | 130.89% | - | - | - | -48.76% | Upgrade
|
| Capital Expenditures | - | -70.02 | -67.67 | -110.76 | -158.45 | -112.78 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.83 | 1.39 | 0.02 | 0.66 | 0.22 | Upgrade
|
| Cash Acquisitions | - | -20.35 | -127.05 | - | -25.84 | -8.95 | Upgrade
|
| Investment in Securities | - | - | - | 21.19 | -5 | -5 | Upgrade
|
| Other Investing Activities | - | 0.07 | 0.29 | 0.62 | 2.04 | 6.26 | Upgrade
|
| Investing Cash Flow | - | -89.46 | -193.04 | -88.93 | -186.59 | -120.25 | Upgrade
|
| Short-Term Debt Issued | - | - | 159.5 | 55.5 | 5 | - | Upgrade
|
| Long-Term Debt Issued | - | 81 | - | - | - | - | Upgrade
|
| Total Debt Issued | - | 81 | 159.5 | 55.5 | 5 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -35.5 | -25 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -73.2 | -9.18 | -16.2 | -14.4 | -1.75 | Upgrade
|
| Total Debt Repaid | - | -73.2 | -44.68 | -41.2 | -14.4 | -1.75 | Upgrade
|
| Net Debt Issued (Repaid) | - | 7.8 | 114.82 | 14.3 | -9.4 | -1.75 | Upgrade
|
| Issuance of Common Stock | - | 15.38 | 9.5 | 103.5 | - | - | Upgrade
|
| Common Dividends Paid | - | -4.11 | -2.01 | -0.94 | -0.03 | -41.33 | Upgrade
|
| Other Financing Activities | - | 42.4 | - | - | - | -0.04 | Upgrade
|
| Financing Cash Flow | - | 61.47 | 122.32 | 116.86 | -9.43 | -43.12 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.21 | -0.9 | -0.95 | -0.75 | -0.86 | Upgrade
|
| Net Cash Flow | - | 103.03 | -14.78 | -84.33 | -256.91 | -93.72 | Upgrade
|
| Free Cash Flow | - | 61.22 | -10.83 | -222.07 | -218.58 | -42.27 | Upgrade
|
| Free Cash Flow Margin | - | 13.35% | -3.16% | -115.15% | -112.46% | -12.91% | Upgrade
|
| Free Cash Flow Per Share | - | 0.16 | -0.03 | -0.55 | -0.54 | -0.10 | Upgrade
|
| Cash Income Tax Paid | - | 29.68 | 22.67 | -3.27 | 1.14 | 46.35 | Upgrade
|
| Levered Free Cash Flow | - | 112.74 | -29.66 | -162.62 | -163.59 | -64.37 | Upgrade
|
| Unlevered Free Cash Flow | - | 112.74 | -27.31 | -161.02 | -162.22 | -64.37 | Upgrade
|
| Change in Net Working Capital | -29.36 | -84.72 | 7.76 | -1.5 | -19.15 | 5.25 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.